Search
Regulatory Story
Company Citadel Group
TIDM IRSH
Headline Form 8.3 - Allergan plc
Released 15:00 26-Mar-2020
Number 7303H

RNS Number : 7303H
Citadel Group
26 March 2020
 
























 

Ap 19

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.         KEY INFORMATION


























Name of person dealing (Note 1)

Citadel Group

Company dealt in

ALLERGAN PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common Stock ISIN IE00BY9D5467

Date of dealing

25 March, 2020

























2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security

                    dealt in (Note 3)









Long

Short

Common Stock  ISIN  IE00BY9D5467

Number        (%)

Number      (%)

(1) Relevant securities

3,288,556 (1.00%)

29,730 (0.01%)

(2) Derivatives (other than options)

3,465,201 (1.05%)

0 (0.00%)

(3) Options and agreements to purchase/sell

0 (0.00%)

0 (0.00%)

Total

6,753,757(2.05%)

29,730 (0.01%)



























 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

























Long

Short


Number        (%)

Number      (%)

(1) Relevant securities



(2) Derivatives (other than options)



(3) Options and agreements to purchase/sell



Total































Ap 20






























1.         DEALINGS (Note 4)

 

(a)        Purchases and sales





























Purchase/sale

Common Stock ISIN IE00BY9D5467

Number of securities

Price per unit (Note 5)

5,661

169  USD

-5,661

169  USD

100

168.86  USD

100

168.89  USD

18,810

169  USD

711

169.5073699  USD

41,627

169.559115  USD

163

169.67828221  USD

1,386

169.68164502  USD

10

169.79  USD

700

169.80642857  USD

48,881

169.8737  USD

732

169.89849727  USD

9,824

169.93135586  USD

6,879

170.02423899  USD

2,842

170.071077  USD

239

170.1067364  USD

2,139

170.10918654  USD

5,225

170.16679234  USD

25,000

170.16725  USD

5,419

170.16824506  USD

3,771

170.2229992  USD

75,000

170.228874  USD

200

170.23  USD

1,620

170.2554321  USD

1,201

170.3864363  USD

1,463

170.40749146  USD

10

170.41  USD

860

170.41023256  USD

22,158

170.565798  USD

100

170.76  USD

235

170.78178723  USD

100

170.83  USD

56,492

170.864221  USD

245

170.88  USD

100

170.89  USD

200

170.92  USD

100

170.94  USD

397

170.96  USD

50

171  USD

50

171.01  USD

100

171.02  USD

300

171.07  USD

100

171.12  USD

100

171.16  USD

100

171.24  USD

100

171.28  USD

100

171.3  USD

158

171.33  USD

100

171.37  USD

-200

168.85  USD

-5,661

169  USD

-1,034

169.4939265  USD

-129

169.6620155  USD

-113

169.69061947  USD

-1,045

169.69666029  USD

-2,572

169.7206804  USD

-8,146

169.7348576  USD

-164

169.77914634  USD

-509

169.78658153  USD

-11,456

169.82716219  USD

-41

169.85  USD

-2,940

169.85128912  USD

-300

169.89  USD

-614

169.90856678  USD

-1,704

169.9183392  USD

-516

169.92736434  USD

-5,710

169.94570578  USD

-24

170.03125  USD

-4,124

170.03401552  USD

-625

170.052736  USD

-1,123

170.11398041  USD

-123

170.17829268  USD

-790

170.23537975  USD

-323

170.31083591  USD

-1,926

170.33540498  USD

-992

170.63726815  USD

-2,415

170.67840166  USD

-220

170.96454545  USD

-1,078

170.97146568  USD

-359

171.23178273  USD

-106

171.77471698  USD





















(b)        Derivatives transactions (other than options transactions)























Product name,

e.g. CFD

 ISIN

Nature of transaction

(Note 6)

 

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

























(c)        Options transactions in respect of existing relevant securities

 

(i)         Writing, selling, purchasing or varying























Product name, e.g. call option

Writing, selling, purchasing,

varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type,

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(Note 5)



























(ii)        Exercising
























Product name,

e.g. call option

Number of securities

Exercise price per unit

(Note 5)






























(d)        Other dealings (including transactions in respect of new securities) (Note 4)




























Nature of transaction

(Note 8)

      Details

      Price per unit

      (if applicable) (Note 5)







 



















Ap 21

















2.         OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 
















Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated

None














Is a Supplemental Form 8 attached? (Note 9)


NO

















 Date of disclosure:

26 March, 2020

 Contact name:

Katie Bonds

 Telephone number:

020 7645 9700

If a connected EFM, name of offeree/offeror with which connected

n/a

If a connected EFM, state nature of connection (Note 10)

n/a





 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISEBBGDXIXDDGGL
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.